Jasper Therapeutics Inc. (JSPRW)
0.11
-0.01 (-8.33%)
At close: Apr 16, 2025, 12:32 PM
-8.33% (1D)
| Bid | n/a |
| Market Cap | 1.73M |
| Revenue (ttm) | 1.17M |
| Net Income (ttm) | 0 |
| EPS (ttm) | -3.836 |
| PE Ratio (ttm) | -0.03 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 65 |
| Avg. Volume (20D) | 8,146.822 |
| Open | 0.07 |
| Previous Close | 0.12 |
| Day's Range | 0.07 - 0.11 |
| 52-Week Range | 0.07 - 0.11 |
| Beta | 2.56 |
About JSPRW
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which ge...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 64
Stock Exchange NASDAQ
Ticker Symbol JSPRW